Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.
PHASE2
The probability to achieve CR with R-chemotherapy in patients failing a rit...
Status
Completed
Location
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Ematologia
Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2
This study aims to evaluate the efficacy and safety of tafasitamab combined...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University